157 related articles for article (PubMed ID: 19351837)
1. Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin.
Okada M; Wang Y; Jang SW; Tang X; Neri LM; Ye K
Cancer Res; 2009 May; 69(9):4043-51. PubMed ID: 19351837
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
Ye K
Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
[TBL] [Abstract][Full Text] [Related]
3. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
[TBL] [Abstract][Full Text] [Related]
4. Merlin sumoylation is required for its tumor suppressor activity.
Qi Q; Liu X; Brat DJ; Ye K
Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
[TBL] [Abstract][Full Text] [Related]
5. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
Rong R; Tang X; Gutmann DH; Ye K
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
[TBL] [Abstract][Full Text] [Related]
7. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
Huang J; Chen J
Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
[TBL] [Abstract][Full Text] [Related]
9. Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44.
Hartmann M; Parra LM; Ruschel A; Böhme S; Li Y; Morrison H; Herrlich A; Herrlich P
Mol Cancer Res; 2015 May; 13(5):879-90. PubMed ID: 25652588
[TBL] [Abstract][Full Text] [Related]
10. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
Kim S; Jho EH
BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
[TBL] [Abstract][Full Text] [Related]
11. FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.
Mani T; Hennigan RF; Foster LA; Conrady DG; Herr AB; Ip W
Mol Cell Biol; 2011 May; 31(10):1983-96. PubMed ID: 21402777
[TBL] [Abstract][Full Text] [Related]
12. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
[TBL] [Abstract][Full Text] [Related]
13. The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.
Hennigan RF; Moon CA; Parysek LM; Monk KR; Morfini G; Berth S; Brady S; Ratner N
Oncogene; 2013 Feb; 32(9):1135-43. PubMed ID: 22525268
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
15. The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.
Ammoun S; Schmid MC; Zhou L; Hilton DA; Barczyk M; Hanemann CO
Mol Oncol; 2015 Jan; 9(1):236-48. PubMed ID: 25217104
[TBL] [Abstract][Full Text] [Related]
16. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
17. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
18. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.
Mandati V; Del Maestro L; Dingli F; Lombard B; Loew D; Molinie N; Romero S; Bouvard D; Louvard D; Gautreau AM; Pasmant E; Lallemand D
J Biol Chem; 2019 Aug; 294(35):12992-13005. PubMed ID: 31296571
[TBL] [Abstract][Full Text] [Related]
20. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]